|
🐜
|
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
34 auth.
Qianghu Wang,
Baoli Hu,
Xin Hu,
Hoon Kim,
M. Squatrito,
L. Scarpace,
A. deCarvalho,
Sali Lyu,
Pengping Li,
Yan Li,
F. Barthel,
H. Cho,
Yu-Hsi Lin,
N. Satani,
Emmanuel Martínez-Ledesma,
...
Siyuan Zheng,
Edward F. Chang,
Charles-Etienne Gabriel Sauvé,
A. Olar,
Zhengdao Lan,
G. Finocchiaro,
J. Phillips,
M. Berger,
Konrad Gabrusiewicz,
Guocan Wang,
E. Eskilsson,
Jian Hu,
T. Mikkelsen,
R. DePinho,
F. Muller,
A. Heimberger,
E. Sulman,
D. Nam,
R. Verhaak
|
10 |
2017 |
10
🐜
|
|
🐜
|
Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.
27 auth.
L. Devy,
Lili Huang,
L. Naa,
N. Yanamandra,
Henk Pieters,
Nicolas Frans,
Edward F. Chang,
Q. Tao,
M. Vanhove,
A. Lejeune,
R. van Gool,
D. Sexton,
Guannan Kuang,
D. Rank,
S. Hogan,
...
C. Pazmany,
Y. Ma,
S. Schoonbroodt,
A. Nixon,
R. Ladner,
R. Hoet,
P. Henderikx,
C. Tenhoor,
S. Rabbani,
M. Valentino,
C. Wood,
D. Dransfield
|
8 |
2009 |
8
🐜
|
|
🐜
|
Erratum: Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment (Cancer Cell (2017) 32(1) (42–56.e6)(S1535610817302532)(10.1016/j.ccell.2017.06.003))
34 auth.
Qianghu Wang,
Baoli Hu,
Xin Hu,
Hoon Kim,
M. Squatrito,
L. Scarpace,
A. deCarvalho,
Sali Lyu,
Pengping Li,
Yan Li,
F. Barthel,
H. Cho,
Yu Lin,
N. Satani,
Emmanuel Martínez-Ledesma,
...
Siyuan Zheng,
Edward F. Chang,
Charles-Etienne Gabriel Sauvé,
A. Olar,
Zhengdao Lan,
G. Finocchiaro,
J. Phillips,
M. Berger,
Konrad Gabrusiewicz,
Guocan Wang,
E. Eskilsson,
Jian Hu,
T. Mikkelsen,
R. DePinho,
F. Muller,
A. Heimberger,
E. Sulman,
D. Nam,
R. Verhaak
|
7 |
2018 |
7
🐜
|
|
🐜
|
University of Birmingham International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference
22 auth.
N. Ueno,
J. R. Espinosa Fernandez,
M. Cristofanilli,
B. Overmoyer,
D. Rea,
Fedor Berdichevski,
Mohamad El-Shinawi,
J. Bellon,
H. Le‐Petross,
A. Lucci,
...
G. Babiera,
S. DeSnyder,
M. Teshome,
Edward F. Chang,
B. Lim,
S. Krishnamurthy,
M. Stauder,
S. Parmar,
M. Mohamed,
Angela Alexander,
V. Valero,
W. Woodward
|
6 |
2018 |
6
🐜
|
|
🐜
|
Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment
22 auth.
Qianghu Wang,
Xin Hu,
Baoli Hu,
F. Muller,
Hoon Kim,
M. Squatrito,
Tom Millelsen,
L. Scarpace,
F. Barthel,
Yu-Hsi Lin,
...
N. Satani,
Emmanuel Martínez-Ledesma,
Edward F. Chang,
A. Olar,
Guocan Wang,
A. deCarvalho,
E. Eskilsson,
Siyuan Zheng,
A. Heimberger,
E. Sulman,
D. Nam,
R. Verhaak
|
5 |
2016 |
5
🐜
|
|
🐜
|
Abstract 4380: IACS-10759: A novel OXPHOS inhibitor which selectively kill tumors with metabolic vulnerabilities
26 auth.
Marina Protopopova,
Madhavi Bandi,
Jennifer P Bardenhagen,
C. Bristow,
C. Carroll,
Edward F. Chang,
Ningping Feng,
M. Do,
J. Greer,
M. Konopleva,
Polina R Matre,
Zhijun Kang,
Gang Liu,
F. Muller,
Timothy E. Lofton,
...
Timothy J. McAfoos,
Yuting Sun,
Melinda G. Smith,
Jay P Theroff,
Y. Wu,
L. Chin,
G. Draetta,
Philip D. Jones,
C. Toniatti,
M. D. Francesco,
J. Marszalek
|
3 |
2015 |
3
🐜
|
|
🐜
|
Abstract 2517: Pharmacodynamic biomarkers for ARQ 736, a small molecule BRAF inhibitor
11 auth.
Yi Yu,
Xiaolan Zhao,
Xiubin Gu,
Edward F. Chang,
Laura A. Cousens,
E. Chiesa,
...
D. Lowe,
Yanbin Liu,
C. Bull,
C. Waghorne,
T. Chan
|
2 |
2010 |
2
🐜
|
|
🐜
|
Abstract A65: IACS-10759: A novel OXPHOS inhibitor that selectively kills tumors with metabolic vulnerabilities
27 auth.
Marina Protopopova,
Madhavi Bandi,
Yuting Sun,
Jennifer P Bardenhagen,
C. Bristow,
C. Carroll,
Edward F. Chang,
Ningping Feng,
M. Do,
J. Greer,
M. Konopleva,
Polina R Matre,
Zhijun Kang,
Gang Liu,
F. Muller,
...
Timothy E. Lofton,
Timothy J. McAfoos,
Melinda G. Smith,
Jay P Theroff,
Jingchao Han,
Yuanqing Wu,
L. Chin,
G. Draetta,
Philip D. Jones,
C. Toniatti,
M. D. Francesco,
J. Marszalek
|
2 |
2016 |
2
🐜
|
|
🐜
|
Abstract A278: ARQ 087, a multi-tyrosine kinase inhibitor with potent in vitro and in vivo activity in FGFR2 driven models.
14 auth.
D. Dransfield,
Jennifer Lee,
C. Waghorne,
C. Bull,
R. Savage,
Xiaolan Zhao,
S. Yuan,
Edward F. Chang,
E. Nakuci,
S. Eathiraj,
...
S. Cornell-Kennon,
Xiubin Gu,
Syed Ali,
Chang-Rung Chen
|
1 |
2013 |
1
🐜
|
|
🐜
|
Abstract B117: Expression of c‐MET and related oncogenic signals in formalin‐fixed paraffin‐embedded human tumors
8 auth.
Laura A. Cousens,
C. Waghorne,
S. Rodig,
Xiubin Gu,
Xiaolan Zhao,
Yi Yu,
...
Edward F. Chang,
T. Chan
|
0 |
2009 |
0
🐜
|
